학술논문
Eptinezumab for the Prevention of Episodic Migraine: Sustained Effect Through 1 Year of Treatment in the PROMISE-1 Study
Document Type
Article
Author
Source
In: Clinical Therapeutics . (Clinical Therapeutics, December 2020, 42(12):2254-2265.e3)
Subject
Language
English
ISSN
1879114X
01492918
01492918